Placemark Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$2.13M Buy
20,840
+1,822
+10% +$178K 0.04% 549
2014
Q3
$1.75M Sell
19,018
-2,156
-10% -$187K 0.03% 601
2014
Q2
$1.74M Buy
21,174
+7,744
+58% +$592K 0.03% 624
2014
Q1
$1.03M Buy
13,430
+2,474
+23% +$193K 0.02% 808
2013
Q4
$759K Buy
10,956
+2,814
+35% +$185K 0.01% 962
2013
Q3
$528K Sell
8,142
-65
-0.8% -$4.11K 0.01% 1065
2013
Q2
$478K Buy
+8,207
New +$469K 0.01% 1056

Other funds holding FBT

Placemark Investments's FBT Position: Q4 2014 in Review

Placemark Investments increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 9.6% in Q4 2014, buying an estimated $178K and bringing the position to 20,840 shares worth $2.13M. The position accounts for 0.04% of the portfolio, ranked #549.

Placemark Investments first reported a position in FBT in Q2 2013 and has held it in 7 quarters since. 112 funds tracked by Wall St. Rank hold FBT as of Q4 2014.

  • Placemark Investments held 20,840 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.13M as of Q4 2014.
  • Placemark Investments bought 1,822 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2014, an estimated $178K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of Placemark Investments's portfolio in Q4 2014, its #549 holding.
  • Placemark Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 7 quarters since.
  • 112 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.